KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Herbalife (HLF) Long-Term Debt Issuances (2017 - 2025)

Herbalife (HLF) has disclosed Long-Term Debt Issuances for 14 consecutive years, with -$270.8 million as the latest value for Q3 2025.

Quarterly Long-Term Debt Issuances fell 179.81% to -$270.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$339.3 million through Sep 2025, down 125.46% year-over-year, with the annual reading at $778.4 million for FY2024, 261.71% up from the prior year.
Long-Term Debt Issuances hit -$270.8 million in Q3 2025 for Herbalife, down from $205.8 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $617.2 million in Q2 2024 to a low of -$600.0 million in Q4 2021.
Historically, Long-Term Debt Issuances has averaged $55.2 million across 5 years, with a median of $79.5 million in 2022.
Biggest YoY gain for Long-Term Debt Issuances was 969.3% in 2024; the steepest drop was 257.67% in 2024.
Year by year, Long-Term Debt Issuances stood at -$600.0 million in 2021, then rose by 27.83% to -$433.0 million in 2022, then soared by 149.7% to $215.2 million in 2023, then tumbled by 257.67% to -$339.3 million in 2024, then grew by 20.19% to -$270.8 million in 2025.
Business Quant data shows Long-Term Debt Issuances for HLF at -$270.8 million in Q3 2025, $205.8 million in Q2 2025, and $65.0 million in Q1 2025.